EUVIMEDEUVIMED entdecken
Crossref

Palmatine mitigates ischemic brain injury by regulating microglial polarization and sphingolipid metabolism

Ningjing Wang, Xiaotong Wei, Peng Zhou, Weizhen Wu, Jiarui Liu, Huaxu Zhu, Zhishu Tang, Xin Chai, Nianyun Yang, Qingyu Zhang, Yinfeng Dong, Rui Guo und 1 weitere

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.115444 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Ningjing Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, …. Hauptthemen laut MEDLINE: Berberine Alkaloids, Microglia, Sphingolipids, Neuroprotective Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Graduate Research and Innovation Projects of Jiangsu Province, Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: To elucidate the therapeutic effects and underlying mechanisms of palmatine, a principal alkaloid derived from Coptis chinensis, on neuroinflammation in ischemic stroke rat models induced by middle cerebral artery occlusion (MCAO). METHODS: Initially, qPCR was employed to assess the impact of neurotrophic factors secreted by SH-SY5Y neuroblastoma cells on the phenotypes of BV2 cells. Alterations in sphingolipid profiles within neuronal supernatants were characterized using liquid chromatography-tandem mass spectrometry, and molecular docking studies were conducted to investigate the interaction of palmatine with key enzymes involved in sphingolipid metabolism. Subsequently, Rats were subjected to MCAO to mimic cerebral ischemia in vivo. Neurological function was evaluated using standardized tests, and brain pathology was assessed. LC-MS/MS was also utilized to quantify sphingolipid levels within the brain. BV2 cells and rats were subjected to TREM2 knockdown using lentiviral transfection and adeno-associated virus (AAV)-mediated delivery, respectively. The neuroprotective effects of palmatine were further delineated. RESULTS: In vitro, palmatine counteracted ischemia-induced microglial M1 polarization, promoting a neuroprotective M2 phenotype in BV2 cells. It modulated sphingolipid metabolism, normalizing ceramide and ceramide-1-phosphate levels in neuronal supernatants. In vivo, palmatine significantly ameliorated neurological deficits and restored sphingolipid homeostasis in MCAO-induced rats. TREM2 downregulation exacerbated ischemic injury, whereas SH-SY5Y-derived neurotrophic factors suppressed BV2 activation. Inhibition of the PI3K/AKT/mTOR/HIF-1α signaling cascade significantly attenuated palmatine's microglia-mediated neuroprotection. CONCLUSION: Palmatine exerts neuroprotection by reducing levels of ceramide through its conversion to ceramide-1-phosphate, a process that is mediated by TREM2 on microglia and the PI3K/AKT/mTOR/HIF-1α signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Berberine AlkaloidsMicrogliaSphingolipidsNeuroprotective AgentsInfarction, Middle Cerebral ArteryBrain IschemiaAnimalsRatsMaleRats, Sprague-DawleyHumansMiceSignal TransductionDisease Models, AnimalTOR Serine-Threonine KinasesCell LinePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Stichwörter der Autor:innen

Cerebral ischemiaMicrogliaNeuroinflammationPalmatineSphingolipid metabolismTREM2

Substanzen

Berberine AlkaloidspalmatineSphingolipidsNeuroprotective AgentsTOR Serine-Threonine KinasesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • Jiangsu Key Laboratory for High Technology Research of TCM Formulae, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • Jiangsu Key Laboratory for High Technology Research of TCM Formulae, Nanjing University of Chinese Medicine, Nanjing 210023, China; Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrializatio…
  • Graduate School, China Academy of Chinese Medical Sciences, Beijing, China.
  • State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
  • School of Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.

Förderung

  • Graduate Research and Innovation Projects of Jiangsu Province
  • Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica
  • National Natural Science Foundation of China
  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • Nanjing University of Chinese Medicine
  • Six Talent Peaks Project in Jiangsu Province
  • Qinglan Project of Jiangsu Province of China

Zitieren

APA

Wang, N., Wei, X., Zhou, P., Wu, W., Liu, J., Zhu, H., Tang, Z., Chai, X., Yang, N., Zhang, Q., Dong, Y., Guo, R., & Zhang, Q. (2025). Palmatine mitigates ischemic brain injury by regulating microglial polarization and sphingolipid metabolism. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115444

Vancouver

Wang N, Wei X, Zhou P, Wu W, Liu J, Zhu H, et al. Palmatine mitigates ischemic brain injury by regulating microglial polarization and sphingolipid metabolism. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115444

BibTeX
@article{Wang2025,
  author = {Wang, Ningjing and Wei, Xiaotong and Zhou, Peng and Wu, Weizhen and Liu, Jiarui and Zhu, Huaxu and Tang, Zhishu and Chai, Xin and Yang, Nianyun and Zhang, Qingyu and Dong, Yinfeng and Guo, Rui and Zhang, Qichun},
  title = {Palmatine mitigates ischemic brain injury by regulating microglial polarization and sphingolipid metabolism},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.115444}
}
Kostenlos starten →